HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Memantine attenuates cell apoptosis by suppressing the calpain-caspase-3 pathway in an experimental model of ischemic stroke.

Abstract
Ischemic stroke, the second leading cause of death worldwide, leads to excessive glutamate release, over-activation of N-methyl-D-aspartate receptor (NMDAR), and massive influx of calcium (Ca2+), which may activate calpain and caspase-3, resulting in cellular damage and death. Memantine is an uncompetitive NMDAR antagonist with low-affinity/fast off-rate. We investigated the potential mechanisms through which memantine protects against ischemic stroke in vitro and in vivo. Middle cerebral artery occlusion-reperfusion (MCAO) was performed to establish an experimental model of ischemic stroke. The neuroprotective effects of memantine on ischemic rats were evaluated by neurological deficit scores and infarct volumes. The activities of calpain and caspase-3, and expression levels of microtubule-associated protein-2 (MAP2) and postsynaptic density-95 (PSD95) were determined by Western blotting. Additionally, Nissl staining and immunostaining were performed to examine brain damage, cell apoptosis, and neuronal loss induced by ischemia. Our results show that memantine could significantly prevent ischemic stroke-induced neurological deficits and brain infarct, and reduce ATP depletion-induced neuronal death. Moreover, memantine markedly suppressed the activation of the calpain-caspase-3 pathway and cell apoptosis, and consequently, attenuated brain damage and neuronal loss in MCAO rats. These results provide a molecular basis for the role of memantine in reducing neuronal apoptosis and preventing neuronal damage, suggesting that memantine may be a promising therapy for stroke patients.
AuthorsBin Chen, Guoxiang Wang, Weiwei Li, Weilin Liu, Ruhui Lin, Jing Tao, Min Jiang, Lidian Chen, Yun Wang
JournalExperimental cell research (Exp Cell Res) Vol. 351 Issue 2 Pg. 163-172 (02 15 2017) ISSN: 1090-2422 [Electronic] United States
PMID28069373 (Publication Type: Journal Article)
CopyrightCopyright © 2017 Elsevier Inc. All rights reserved.
Chemical References
  • Culture Media
  • Disks Large Homolog 4 Protein
  • Dlg4 protein, rat
  • Intracellular Signaling Peptides and Proteins
  • MAP2 protein, rat
  • Membrane Proteins
  • Microtubule-Associated Proteins
  • Neuroprotective Agents
  • Adenosine Triphosphate
  • Calpain
  • Casp3 protein, rat
  • Caspase 3
  • Glucose
  • Memantine
Topics
  • Adenosine Triphosphate (deficiency)
  • Animals
  • Apoptosis (drug effects)
  • Brain Ischemia (drug therapy, genetics, metabolism, pathology)
  • Calpain (antagonists & inhibitors, genetics, metabolism)
  • Caspase 3 (genetics, metabolism)
  • Cerebral Arteries (surgery)
  • Cerebrovascular Disorders (surgery)
  • Culture Media (pharmacology)
  • Disks Large Homolog 4 Protein
  • Gene Expression Regulation
  • Glucose (deficiency)
  • Hippocampus (drug effects, metabolism, pathology)
  • Humans
  • Intracellular Signaling Peptides and Proteins (genetics, metabolism)
  • Memantine (pharmacology)
  • Membrane Proteins (genetics, metabolism)
  • Microtubule-Associated Proteins (genetics, metabolism)
  • Neurons (drug effects, metabolism, pathology)
  • Neuroprotective Agents (pharmacology)
  • Primary Cell Culture
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction
  • Stroke (drug therapy, genetics, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: